Transcatheter vs. surgical aortic valve replacement and medical treatment : Systematic review and meta-analysis of randomized and non-randomized trials.
A AkI PorokhovnikovF KuetheP C SchulzeMichel NoutsiasP SchlattmannPublished in: Herz (2017)
In AS, both TAVR and SAVR provide a superior prognosis to MT and, therefore, MT is not the preferred treatment option for AS. Furthermore, our data show that TAVR is associated with lower mortality at 12 months compared with SAVR. Further studies are warranted to compare the long-term outcome of TAVR versus SAVR beyond a 2-year follow-up period.
Keyphrases
- aortic valve
- aortic stenosis
- aortic valve replacement
- transcatheter aortic valve replacement
- transcatheter aortic valve implantation
- healthcare
- ejection fraction
- type diabetes
- open label
- cardiovascular events
- left ventricular
- double blind
- risk factors
- coronary artery disease
- study protocol
- deep learning
- phase iii
- replacement therapy
- case control